Clinical trials
Inflammatory Bowel Diseases clinical trials
Below are recruiting inflammatory bowel diseases clinical trials, each written for real people, not researchers. We’re tracking 256 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07737665RecruitingPhase 4
Melatonin for better sleep in IBD patients in remission
This study tests whether melatonin (a natural sleep hormone) can improve sleep quality in people with inflammatory bowel disease (IBD) whose disease is quiet (in remission). If you have IBD and trouble sleeping, you may be able to join.
Bangkok Noi, BangkokAges 18 years+ - NCT07716488Recruiting
Screening for high cholesterol in children with chronic conditions
This study screens children and teens with certain chronic conditions (like heart defects or inflammatory bowel disease) for early signs of high cholesterol or other lipid problems. The goal is to find and manage these risks sooner.
JenaAges 6–18 - NCT06648551Recruiting
Nutrition screening tool for inflammatory bowel disease
This study checks if a simple nutrition test can accurately identify malnutrition in people with ulcerative colitis. It may help doctors better monitor your nutritional health.
Mexico City, CuauhtemocAges 18–80 - NCT07686406Recruiting
IBD biomarker discovery study
This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.
Guangzhou, GuangdongAges 14 years+ - NCT07670988Recruiting
Kidney health in kids with inflammatory bowel disease
This study checks if children with inflammatory bowel disease (IBD) are more likely to have kidney problems. Researchers will look at medical records to compare kidney health in kids with IBD and those without.
Alessandria, PiedmontAges 2–17 - NCT07670975Recruiting
Energy use in children with new IBD diagnosis
This study measures how many calories children with newly diagnosed inflammatory bowel disease (Crohn's or ulcerative colitis) burn at rest. It helps doctors understand and manage their energy needs.
Alessandria, PiedmontAges 6–17 - NCT07644117Recruiting
Personalized Anti-TNF Treatment for Inflammatory Bowel Disease
This trial tests a personalized approach to starting anti-TNF therapy—a common treatment for inflammatory bowel disease (IBD)—in patients who have never taken it before. The goal is to help doctors choose the right anti-TNF medication and dose based on each patient's individual characteristics.
Tel AvivAges 18 years+ - NCT04867408Recruiting
Using bowel scope images to improve inflammatory bowel disease training
This study uses pictures taken during routine bowel scope (endoscopy) to build and test a computer system for training and research in inflammatory bowel disease. It may help doctors and trainees interpret scope images more consistently over time.
Hull, East YorkshireAges 16–99 - NCT07632573RecruitingPhase 1
Safety Study of BDHK-2009 Tablets in Healthy Adults
This is an early-stage safety study testing a new experimental tablet called BDHK-2009 in healthy volunteers with no major illnesses. Researchers want to make sure the drug is safe and well-tolerated before testing it in people with medical conditions.
Hangzhou, ZhejiangAges 18–55 - NCT07636304Enrolling by invitationEarly Phase 1
Brain stimulation for inflammatory bowel disease remission
This study tests whether a non-invasive device that stimulates the vagus nerve (a major nerve in your neck) can affect brain function in people whose IBD is in remission. Researchers want to understand if this stimulation might help reduce inflammation or improve symptoms in the future.
Gdansk, Pomeranian VoivodeshipAges 18 years+ - NCT03953768Recruiting
Testing a new vagus nerve stimulator for gut and immune health
This study looks at what happens to your immune system and stomach/gut function after getting a vagus nerve stimulator (VNS) for the first time for epilepsy. It may help doctors understand whether the device benefits more than seizures.
Louisville, KentuckyAges birth–60 years - NCT04191395Recruiting
Study of treatments for long-term inflammatory diseases
This study looks at how chronic inflammatory illnesses progress over time and how treatments affect symptoms and disease markers. You may be invited if you’re receiving care for certain bowel, joint, or skin inflammatory conditions at the hospital.
BesançonAges 18 years+ - NCT07593352Recruiting
Kidney Health in Inflammatory Bowel Disease Patients
This study compares kidney function between people with inflammatory bowel disease (IBD) and those without it. Researchers want to understand if IBD affects the kidneys and why, which could help protect kidney health in IBD patients.
Warsaw, WarszawaAges 18–80 - NCT06721767Recruiting
IBD monitoring study at a regional center
This trial is a monitoring study for people with inflammatory bowel diseases (IBD), such as Crohn's disease or ulcerative colitis. It aims to follow patients who have been seen at a specialized IBD center to gather information and improve care.
BolognaAges 14 years+ - NCT07582731Recruiting
Video Education to Improve Colonoscopy Preparation in IBD
This study tests whether personalized video lessons tailored to your specific type of inflammatory bowel disease (Crohn's disease or ulcerative colitis) help you prepare better for a colonoscopy. Better preparation means clearer pictures during the procedure, which helps doctors see your disease more accurately.
Beijing, BeijingBeijingAges 18–75 - NCT07582458RecruitingPhase 2/Phase 3
Modafinil for Fatigue in Controlled Inflammatory Bowel Disease
This trial tests whether modafinil (a wakefulness-promoting medication) can reduce severe fatigue in people with inflammatory bowel disease (IBD) whose disease is well-controlled. If you have persistent exhaustion despite your IBD being stable, this study may help determine if this medication works for you.
Arnhem, GelderlandAges 18–75 - NCT06059989RecruitingPhase 3
Testing a new form of infliximab for Crohn's disease
This trial is testing a new way to give infliximab, a treatment for moderate to severe Crohn's disease, as a shot under the skin. It's for people who haven't gotten better with other treatments or need strong medication right away.
Amsterdam, North HollandAges 18–80 - NCT07532213Recruiting
Real-world outcomes of guselkumab for ulcerative colitis or Crohn's disease
This study tracks how well guselkumab (a biologic medication that blocks IL-23, a protein that drives inflammation) works for moderate-to-severe ulcerative colitis or Crohn's disease in everyday clinical practice. Researchers want to understand long-term benefits and safety in real patients.
BernAges 18 years+ - NCT07533890Recruiting
Probiotics and gut health in children with inflammatory bowel disease
This study tests whether a multi-strain probiotic supplement can change the gut bacteria in children and teens with inflammatory bowel disease (IBD). Researchers will collect stool samples to see if the probiotics help restore healthy gut bacteria and potentially improve symptoms.
BernAges 5–18 - NCT06756100Recruiting
Early inflammatory bowel disease study
This trial looks at early signs of inflammatory bowel disease (IBD) in adults who have had stomach or bowel symptoms for at least 3 weeks. It aims to understand how the disease progresses.
SantiagoAges 18–100 - NCT07520747Recruiting
Korean Children's IBD Disease and Treatment Database Study
This study looks at health records of children in Korea who have inflammatory bowel disease (Crohn's disease or ulcerative colitis) to understand their medical care, treatments, and healthcare use. Researchers are not testing a new drug—they're analyzing existing medical information to learn more about how these diseases are managed in children.
SuwonAges Up to 17 years - NCT07513181RecruitingPhase 2
Testing ATH-063 for Hard-to-Treat Ulcerative Colitis
This study tests a new drug called ATH-063 to see if it can help people with moderate-to-severe ulcerative colitis (a condition causing inflammation and bleeding in the colon) who haven't responded well to previous biologic treatments. The goal is to find out if this new drug is safe and effective.
Miami, FloridaAges 18–75 - NCT07487311Recruiting
Study of guselkumab plus JAK inhibitors for tough-to-treat IBD
This trial tests a combination of two medications—guselkumab and a JAK inhibitor—for people with inflammatory bowel disease that hasn't responded to other treatments. The goal is to see if this combination is safe and effective for patients with hard-to-control Crohn's disease or ulcerative colitis.
Hangzhou, ZhejiangAges 14–80 - NCT06780683Recruiting
Testing upadacitinib for inflammatory bowel disease
This study tests a medication called upadacitinib for people with inflammatory bowel disease (ulcerative colitis or Crohn's). The goal is to see how well it works and if it's safe.
Guangzhou, GuangdongAges Any age
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for inflammatory bowel diseases?
- Yes. Clin2 currently lists 256 recruiting inflammatory bowel diseases studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a inflammatory bowel diseases trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a inflammatory bowel diseases trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.